These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 23461062)
1. Downregulation of JWA expression in human esophageal squamous cell carcinoma and its clinical significance. Zhou J; Ge Z; Tan Y; Jiang G; Feng J; Wang H; Shi G Oncol Res; 2012; 20(4):157-62. PubMed ID: 23461062 [TBL] [Abstract][Full Text] [Related]
2. Effects of JWA, XRCC1 and BRCA1 mRNA expression on molecular staging for personalized therapy in patients with advanced esophageal squamous cell carcinoma. Wei B; Han Q; Xu L; Zhang X; Zhu J; Wan L; Jin Y; Qian Z; Wu J; Gao Y; Zhou J; Chen X BMC Cancer; 2015 Apr; 15():331. PubMed ID: 25925371 [TBL] [Abstract][Full Text] [Related]
3. Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma. Ren HZ; Pan GQ; Wang JS; Wen JF; Wang KS; Luo GQ; Shan XZ Dig Dis Sci; 2010 Sep; 55(9):2552-60. PubMed ID: 20108042 [TBL] [Abstract][Full Text] [Related]
4. MiR-455-3p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM83F. Yang H; Wei YN; Zhou J; Hao TT; Liu XL Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3200-3206. PubMed ID: 28770965 [TBL] [Abstract][Full Text] [Related]
5. Expression and clinical significance of REPS2 in human esophageal squamous cell carcinoma. Zhang H; Duan CJ; Zhang H; Cheng YD; Zhang CF Asian Pac J Cancer Prev; 2013; 14(5):2851-7. PubMed ID: 23803043 [TBL] [Abstract][Full Text] [Related]
6. Expression of Bmi-1 and PAI-1 in esophageal squamous cell carcinoma. Zhang Y; Zhang YL; Chen HM; Pu HW; Ma WJ; Li XM; Ma H; Chen X World J Gastroenterol; 2014 May; 20(18):5533-9. PubMed ID: 24833884 [TBL] [Abstract][Full Text] [Related]
7. PRAF3 induces apoptosis and inhibits migration and invasion in human esophageal squamous cell carcinoma. Shi GZ; Yuan Y; Jiang GJ; Ge ZJ; Zhou J; Gong DJ; Tao J; Tan YF; Huang SD BMC Cancer; 2012 Mar; 12():97. PubMed ID: 22433565 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma. Qi B; Lu JG; Yao WJ; Chang TM; Qin XG; Ji YH; Wang TY; Liu SG; Li HC; Liu YZ; Zhao BS World J Gastroenterol; 2015 Jun; 21(22):6884-91. PubMed ID: 26078564 [TBL] [Abstract][Full Text] [Related]
9. Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma. Hsu PK; Kao HL; Chen HY; Yen CC; Wu YC; Hsu WH; Chou TY J Thorac Cardiovasc Surg; 2014 May; 147(5):1612-1618.e4. PubMed ID: 24263008 [TBL] [Abstract][Full Text] [Related]
10. Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis. Zhu X; Jin H; Xia Z; Wu X; Yang M; Zhang H; Shang X; Cheng R; Zhan Z; Yu Z Biochem Biophys Res Commun; 2017 Apr; 486(2):571-576. PubMed ID: 28336434 [TBL] [Abstract][Full Text] [Related]
11. Upregulated ataxia-telangiectasia group D complementing gene correlates with poor prognosis in patients with esophageal squamous cell carcinoma. Lai W; Zhao J; Zhang C; Cui D; Lin J; He Y; Zheng H; Wu X; Yang M Dis Esophagus; 2013; 26(8):817-22. PubMed ID: 23020249 [TBL] [Abstract][Full Text] [Related]
12. Expression and clinical significance of C14orf166 in esophageal squamous cell carcinoma. Zhou YW; Li R; Duan CJ; Gao Y; Cheng YD; He ZW; Zeng JX; Zhang CF Mol Med Rep; 2017 Feb; 15(2):605-612. PubMed ID: 28000881 [TBL] [Abstract][Full Text] [Related]
13. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma]. Zhang Y; Liu YP; Du K; Wang H; Wang XL Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219 [TBL] [Abstract][Full Text] [Related]
14. DJ-1 could predict worse prognosis in esophageal squamous cell carcinoma. Yuen HF; Chan YP; Law S; Srivastava G; El-Tanani M; Mak TW; Chan KW Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3593-602. PubMed ID: 19064576 [TBL] [Abstract][Full Text] [Related]
15. Intensive expression of UNC-51-like kinase 1 is a novel biomarker of poor prognosis in patients with esophageal squamous cell carcinoma. Jiang S; Li Y; Zhu YH; Wu XQ; Tang J; Li Z; Feng GK; Deng R; Li DD; Luo RZ; Zhang MF; Qin W; Wang X; Jia WH; Zhu XF Cancer Sci; 2011 Aug; 102(8):1568-75. PubMed ID: 21518141 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of PDK1 associates with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro. Yang Z; Wu Z; Liu T; Han L; Wang C; Yang B; Zheng F Med Oncol; 2014 Dec; 31(12):337. PubMed ID: 25416048 [TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological and prognostic significance of the expression of ADAM17 mRNA and protein in esophageal squamous cell carcinoma]. Liu HB; Yang QC; Shen Y; Zhu Y; Zhang XJ; Chen H Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):361-5. PubMed ID: 24054013 [TBL] [Abstract][Full Text] [Related]
18. The tumor-suppressive role of BATF2 in esophageal squamous cell carcinoma. Han T; Wang Z; Yang Y; Shu T; Li W; Liu D; Li P; Qi R; Ren Y; Li L; Liu H; Zhang S; Zhang L Oncol Rep; 2015 Sep; 34(3):1353-60. PubMed ID: 26135942 [TBL] [Abstract][Full Text] [Related]
19. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma. Wei R; Shang Z; Leng J; Cui L J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242 [TBL] [Abstract][Full Text] [Related]
20. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma. Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]